Stereotaxis is trading 5.84% up at $1.45, with no clear catalyst identified after closing at $1.37 on September 1, 2026.
- No company-specific announcement or earnings release was identified for September 2; the official release list shows the latest update was August 11.
- Broader futures remain mixed amid geopolitical and rate concerns.
- Earlier coverage cited a Citizens price-target reduction, which predates this move.